Seminar Topics
SEMINAR
PRIYANGA P RAO
S7 EC
ROLL NO: 41
VERICHIP
VeriChip is the only Food and Drug Administration (FDA)-approved human-implantable radio-frequency identification (RFID) microchip. It is marketed by PositiveID, a subsidiary of Applied Digital Solutions, and it received United States FDA approval in 2004. About twice the length of a dime, the device is typically implanted between the shoulder and elbow area of an individual’s right arm.Once scanned at the proper frequency, the VeriChip responds with a unique 16 digit number which could be then linked with information about the user held on a database for identity verification, medical records access and other uses. The insertion procedure is performed under local anesthetic in a physician's office. As an implanted device used for identification by a third party, it has generated controversy and debate. Planned future uses for VeriChip include a variety of financial, security, defense, homeland security and secure-access applications. ASDX sees its product as "tamper-proof personal identification" for use in credit card and ATM access, airport security, and port congestion management, as well as admission to military bases, government installations, and private-sector buildings. The system is marketed as a stand-alone product or for use in conjunction with biometric devices. ASDX has started a marketing campaign under the slogan "Get Chipped", that includes a traveling van called the "ChipMobile".
VeriChip Corporation is a wholly owned subsidiary of Applied Digital Solutions, Inc (ASDX). According to a recent report filed with the Securities and Exchange Commission, ASDX "focuses on a range of life enhancing, personal safeguard technologies, early warning alert systems, miniaturized power sources and security monitoring systems combined with the comprehensive data management services required to support them". ASDX customers include several federal agencies, such as Departments of
PRIYANGA P RAO
S7 EC
ROLL NO: 41
VERICHIP
VeriChip is the only Food and Drug Administration (FDA)-approved human-implantable radio-frequency identification (RFID) microchip. It is marketed by PositiveID, a subsidiary of Applied Digital Solutions, and it received United States FDA approval in 2004. About twice the length of a dime, the device is typically implanted between the shoulder and elbow area of an individual’s right arm.Once scanned at the proper frequency, the VeriChip responds with a unique 16 digit number which could be then linked with information about the user held on a database for identity verification, medical records access and other uses. The insertion procedure is performed under local anesthetic in a physician's office. As an implanted device used for identification by a third party, it has generated controversy and debate. Planned future uses for VeriChip include a variety of financial, security, defense, homeland security and secure-access applications. ASDX sees its product as "tamper-proof personal identification" for use in credit card and ATM access, airport security, and port congestion management, as well as admission to military bases, government installations, and private-sector buildings. The system is marketed as a stand-alone product or for use in conjunction with biometric devices. ASDX has started a marketing campaign under the slogan "Get Chipped", that includes a traveling van called the "ChipMobile".
VeriChip Corporation is a wholly owned subsidiary of Applied Digital Solutions, Inc (ASDX). According to a recent report filed with the Securities and Exchange Commission, ASDX "focuses on a range of life enhancing, personal safeguard technologies, early warning alert systems, miniaturized power sources and security monitoring systems combined with the comprehensive data management services required to support them". ASDX customers include several federal agencies, such as Departments of